BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/22/2023 8:49:19 AM | Browse: 340 | Download: 1131
 |
Received |
|
2023-09-14 09:22 |
|
Peer-Review Started |
|
2023-09-13 17:16 |
|
First Decision by Editorial Office Director |
|
2023-12-05 02:15 |
|
Return for Revision |
|
2023-12-05 02:15 |
|
Revised |
|
2023-12-05 08:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-12-12 03:02 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-12-12 06:29 |
|
Articles in Press |
|
2023-12-12 06:29 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-12-15 09:33 |
|
Publish the Manuscript Online |
|
2023-12-22 08:49 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis and Andrew Xanthopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Andrew Xanthopoulos, FACC, MD, PhD, Senior Postdoctoral Fellow, Department of Cardiology, University Hospital of Larissa, Mezourlo, Larissa 41110, Greece. andrewvxanth@gmail.com |
| Key Words |
Heart failure; Recombinant; Brain natriuretic peptide; Outcomes |
| Core Tip |
Lyophilized recombinant brain natriuretic peptide is an exogenous peptide synthesized by artificial recombination technology, with a similar structure and similar physiological effects with the endogenous natriuretic peptide secreted by the human body. A recent single center, randomized study examined its safety and efficacy in 102 chronic heart failure patients, showing promising results. Larger randomized controlled trials are urgently needed. |
| Publish Date |
2023-12-22 08:49 |
| Citation |
Kourek C, Briasoulis A, Giamouzis G, Skoularigis J, Xanthopoulos A. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World J Clin Cases 2023; 11(36): 8603-8605 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i36/8603.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i36.8603 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
